The effect of race on composite thrombotic events in patients with COVID-19. Issue 199 (March 2021)

• Record Type: Journal Article
• Authors: Esenwa, Charles; Unda, Santiago R.; Altschul, David J.; Patel, Nikunj K.; Malaviya, Avinash; Seiden, Johanna; Lendaris, Andrea; Moncrieffe, Khadean; Labovitz, Daniel L.
• Is Part Of: Thrombosis research. Issue 199(2021)
• Page Start: 10
• Page End: 13
• Publication Date: 2021-03
• Subjects: COVID-19 coronavirus disease 2019 -- NYC New York City -- AIS acute ischemic stroke -- PE pulmonary embolism -- MI myocardial infarction -- DVT deep vein thrombosis -- AA African American -- NHW non-Hispanic white -- SES socioeconomic status; COVID-19 -- Racial disparities -- Thrombosis -- Stroke; Thrombosis -- Periodicals; 616.135
• DOI: 10.1016/j.thromres.2020.12.015
• Languages: English
• ISSNs: 0049-3848

Abstract

Abstract: COVID-19 associated coagulopathy and mortality related to thrombotic complications have been suggested as biological mediators in racial disparities related to COVID-19. We studied the adjusted prevalence of acute ischemic stroke, pulmonary embolism, myocardial infarction, and deep venous thrombosis stratified by race in hospitalized patients in one New York City borough during the local COVID-19 surge. The multi-racial cohort included 4299 patients hospitalized with COVID-19, 9% of whom were white, 40% black, 41% Hispanic and 10% Asian or other. We found a 6.1% prevalence of composite thrombotic events. There were no significant race-specific differences in thrombotic events when adjusting for basic demographics, socioeconomic factors, medical comorbidities or biomarkers using a stepwise regression model. We therefore found no evidence that the racial disparities related to COVID-19, and specifically thrombotic complications, are caused by biological differences in race.